<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<ReleaseSet Dated="2016-07-04" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" Type="full" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/clinvar_public_1.35.xsd">

<ClinVarSet ID="38058859"><RecordStatus>current</RecordStatus><Title>NM_000059.3(BRCA2):c.-26G&gt;A AND Breast-ovarian cancer, familial 2</Title><ReferenceClinVarAssertion DateCreated="2014-03-30" DateLastUpdated="2019-02-04" ID="266125"><ClinVarAccession Acc="RCV000112977" Version="3" Type="RCV" DateUpdated="2019-02-04" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2015-01-12"><ReviewStatus>reviewed by expert panel</ReviewStatus><Description>Benign</Description></ClinicalSignificance><Assertion Type="variation to disease" /><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="36941491"><Attribute integerValue="200" Type="VariantAlleles" /></ObservedData><ObservedData ID="36941491"><Attribute Type="Description">not provided</Attribute></ObservedData><ObservedData ID="36941491"><Attribute Type="Description">not provided</Attribute></ObservedData><ObservedData ID="36941491"><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Ethnicity>Caucasian</Ethnicity><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="36941492"><Attribute integerValue="5" Type="VariantAlleles" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Ethnicity>Caucasian Southern African</Ethnicity><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="36941493"><Attribute integerValue="6" Type="VariantAlleles" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Ethnicity>European, Asian, Oceanan</Ethnicity><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="36941494"><Attribute integerValue="1" Type="VariantAlleles" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Ethnicity>Sinhalese</Ethnicity><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="36941495"><Attribute integerValue="1" Type="VariantAlleles" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>not provided</AffectedStatus><NumberTested>86</NumberTested></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="36941496"><Attribute integerValue="86" Type="VariantAlleles" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>curation</MethodType></Method><ObservedData ID="36941497"><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><ObservedIn><Sample><Origin>not provided</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="36941498"><Attribute integerValue="1" Type="VariantAlleles" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>unknown</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="36941499"><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant" ID="125965"><Measure Type="single nucleotide variant" ID="131503"><Name><ElementValue Type="Preferred">NM_000059.3(BRCA2):c.-26G&gt;A</ElementValue></Name><Name><ElementValue Type="Alternate">203G/A</ElementValue></Name><Name><ElementValue Type="Alternate">203G&gt;A</ElementValue></Name><Name><ElementValue Type="Alternate">203 G&gt;A</ElementValue></Name><AttributeSet><Attribute Change="c.-26G&gt;A" Accession="LRG_293t1" Type="HGVS, coding, LRG">LRG_293t1:c.-26G&gt;A</Attribute></AttributeSet><AttributeSet><Attribute Change="c.-26G&gt;A" Accession="NM_000059" Version="3" Type="HGVS, coding, RefSeq">NM_000059.3:c.-26G&gt;A</Attribute><XRef ID="12084" DB="Illumina Clinical Services Laboratory,Illumina" /></AttributeSet><AttributeSet><Attribute Change="g.5956G&gt;A" Accession="LRG_293" Type="HGVS, genomic, LRG">LRG_293:g.5956G&gt;A</Attribute></AttributeSet><AttributeSet><Attribute Change="g.5956G&gt;A" Accession="NG_012772" Version="3" Type="HGVS, genomic, RefSeqGene">NG_012772.3:g.5956G&gt;A</Attribute></AttributeSet><AttributeSet><Attribute Change="g.32316435G&gt;A" Accession="NC_000013" Version="11" Type="HGVS, genomic, top level" integerValue="38">NC_000013.11:g.32316435G&gt;A</Attribute></AttributeSet><AttributeSet><Attribute Change="g.32890572G&gt;A" Accession="NC_000013" Version="10" Type="HGVS, genomic, top level, previous" integerValue="37">NC_000013.10:g.32890572G&gt;A</Attribute></AttributeSet><AttributeSet><Attribute Change="n.203G&gt;A" Accession="U43746" Version="1" Type="HGVS, non-coding">U43746.1:n.203G&gt;A</Attribute></AttributeSet><AttributeSet><Attribute Type="Location">NM_000059.3:exon 2</Attribute></AttributeSet><AttributeSet><Attribute Type="Location">U43746.1:exon 2</Attribute></AttributeSet><AttributeSet><Attribute Type="MolecularConsequence">5 prime UTR variant</Attribute><XRef ID="SO:0001623" DB="Sequence Ontology" /><XRef ID="NM_000059.3:c.-26G&gt;A" DB="RefSeq" /></AttributeSet><AttributeSet><Attribute Type="nucleotide change">5'UTR203G&gt;A</Attribute></AttributeSet><AlleleFrequencyList><AlleleFrequency Value="0.20883" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" /><AlleleFrequency Value="0.20927" Source="1000 Genomes Project" /><AlleleFrequency Value="0.24652" Source="Exome Aggregation Consortium (ExAC)" /><AlleleFrequency Value="0.22081" Source="The Genome Aggregation Database (gnomAD)" /><AlleleFrequency Value="0.24551" Source="The Genome Aggregation Database (gnomAD), exomes" /><AlleleFrequency Value="0.21567" Source="Trans-Omics for Precision Medicine (TOPMed)" /></AlleleFrequencyList><GlobalMinorAlleleFrequency Value="0.20927" Source="1000 Genomes Project" MinorAllele="A" /><CytogeneticLocation>13q13.1</CytogeneticLocation><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="32316435" stop="32316435" display_start="32316435" display_stop="32316435" variantLength="1" referenceAllele="G" alternateAllele="A" positionVCF="32316435" referenceAlleleVCF="G" alternateAlleleVCF="A" /><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="32890572" stop="32890572" display_start="32890572" display_stop="32890572" variantLength="1" referenceAllele="G" alternateAllele="A" positionVCF="32890572" referenceAlleleVCF="G" alternateAlleleVCF="A" /><MeasureRelationship Type="within single gene"><Name><ElementValue Type="Preferred">BRCA2 DNA repair associated</ElementValue></Name><Symbol><ElementValue Type="Preferred">BRCA2</ElementValue></Symbol><AttributeSet><Attribute dateValue="2012-07-06" Type="Haploinsufficiency">Sufficient evidence for dosage pathogenicity</Attribute><Citation><URL>https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA2</URL></Citation></AttributeSet><AttributeSet><Attribute dateValue="2012-07-06" Type="Triplosensitivity">No evidence available</Attribute><Citation><URL>https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BRCA2</URL></Citation></AttributeSet><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="32315480" stop="32399672" display_start="32315480" display_stop="32399672" Strand="+" /><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="32889616" stop="32973808" display_start="32889616" display_stop="32973808" variantLength="84193" Strand="+" /><XRef ID="675" DB="Gene" /><XRef Type="MIM" ID="600185" DB="OMIM" /><XRef ID="HGNC:1101" DB="HGNC" /><Comment DataSource="NCBI curation" Type="public">This gene is cited in the ACMG recommendations of 2013 (PubMed 23788249) for reporting incidental findings in exons.</Comment><Comment DataSource="NCBI curation" Type="public">This gene is cited in the ACMG recommendations of 2016 (PubMed 27854360) for reporting incidental findings in exons.</Comment></MeasureRelationship><XRef ID="203&amp;base_change=G to A" DB="Breast Cancer Information Core (BIC) (BRCA2)" /><XRef Type="rs" ID="1799943" DB="dbSNP" /></Measure><Name><ElementValue Type="Preferred">NM_000059.3(BRCA2):c.-26G&gt;A</ElementValue></Name><XRef ID="CA016113" DB="ClinGen" /></MeasureSet><TraitSet Type="Disease" ID="2560"><Trait ID="636" Type="Disease"><Name><ElementValue Type="Preferred">Breast-ovarian cancer, familial 2</ElementValue><XRef ID="Breast-ovarian+cancer%2C+familial+2/7866" DB="Genetic Alliance" /></Name><Name><ElementValue Type="Alternate">BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2</ElementValue><XRef Type="MIM" ID="612555" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0001" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0002" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0003" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0004" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0005" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0006" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0007" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0008" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0009" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0010" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0011" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0012" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0014" DB="OMIM" /><XRef Type="Allelic variant" ID="600185.0016" DB="OMIM" /></Name><Name><ElementValue Type="Alternate">BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2</ElementValue><XRef ID="612555" DB="OMIM" /></Name><Name><ElementValue Type="Alternate">Breast cancer, familial 2</ElementValue></Name><Symbol><ElementValue Type="Preferred">BROVCA2</ElementValue><XRef Type="MIM" ID="612555" DB="OMIM" /></Symbol><Symbol><ElementValue Type="Alternate">HBOC</ElementValue><XRef ID="GTR000501744" DB="Genetic Testing Registry (GTR)" /></Symbol><Symbol><ElementValue Type="Alternate">BRCA2</ElementValue><XRef ID="GTR000501818" DB="Genetic Testing Registry (GTR)" /></Symbol><AttributeSet><Attribute Type="public definition">BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.</Attribute><XRef ID="NBK1247" DB="GeneReviews" /></AttributeSet><AttributeSet><Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute><XRef ID="GTR000017874" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000021468" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000320777" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000325401" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000326160" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000330054" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000501744" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000501748" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000501818" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000505644" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000507653" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000507764" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000507913" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000507930" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509001" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509002" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509348" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509349" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509450" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509451" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509692" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509980" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509984" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000509985" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000512644" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000512816" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000519030" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520071" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520072" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520394" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520410" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520865" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520866" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520867" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520869" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520870" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520871" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000520872" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000522159" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000522160" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000522162" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000522243" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000527942" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000528915" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000528916" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000530707" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000531275" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000531340" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000551447" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000552304" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000562228" DB="Genetic Testing Registry (GTR)" /></AttributeSet><AttributeSet><Attribute Type="keyword">Neoplasm</Attribute></AttributeSet><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">20301425</ID><ID Source="BookShelf">NBK1247</ID></Citation><Citation Type="practice guideline" Abbrev="ACS, 2007"><ID Source="PubMed">17392385</ID></Citation><Citation Type="Position Statement" Abbrev="ASCO, 2010"><ID Source="PubMed">20065170</ID></Citation><Citation Type="practice guideline" Abbrev="NSGC, 2004"><ID Source="PubMed">15604628</ID></Citation><Citation Type="practice guideline" Abbrev="NSGC, 2007"><ID Source="PubMed">17508274</ID></Citation><Citation Type="practice guideline" Abbrev="ACOG, 2009"><ID Source="PubMed">19305347</ID></Citation><Citation Type="Recommendation" Abbrev="ACMG, 2013"><ID Source="PubMed">23788249</ID></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2013"><URL>http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf</URL><CitationText>National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian</CitationText></Citation><Citation Type="Suggested Reading" Abbrev="Phillips et al., 2013"><ID Source="PubMed">23918944</ID></Citation><Citation Type="Suggested Reading" Abbrev="Domchek et al., 2010"><ID Source="pmc">2948529</ID></Citation><Citation Type="practice guideline" Abbrev="ASCO, 2014"><ID Source="PubMed">24493721</ID></Citation><Citation Type="practice guideline" Abbrev="USPSTF, 2014"><ID Source="PubMed">24366376</ID></Citation><Citation Type="practice guideline" Abbrev="CAPS, 2013"><ID Source="pmc">3585492</ID></Citation><Citation Type="practice guideline" Abbrev="NSGC, 2013"><ID Source="PubMed">23188549</ID></Citation><Citation Type="practice guideline" Abbrev="ACMG/NSGC, 2015"><ID Source="PubMed">25394175</ID></Citation><Citation Type="Recommendation" Abbrev="USPSTF, 2014"><ID Source="PubMed">24366402</ID></Citation><Citation Type="Recommendation" Abbrev="USPSTF, 2013"><ID Source="PubMed">24432435</ID></Citation><Citation Type="Recommendation" Abbrev="ACMG, 2015"><ID Source="PubMed">25356965</ID></Citation><Citation Type="Recommendation" Abbrev="ACMG, 2016"><ID Source="PubMed">27854360</ID><ID Source="DOI">10.1038/gim.2016.190</ID></Citation><XRef ID="C2675520" DB="MedGen" /><XRef ID="145" DB="Orphanet" /><XRef Type="MIM" ID="612555" DB="OMIM" /></Trait></TraitSet></ReferenceClinVarAssertion><ClinVarAssertion ID="262846"><ClinVarSubmissionID localKey="U43746.1:n.203G&gt;A|MedGen:C2675520" submitter="Breast Cancer Information Core (BIC) (BRCA2)" submitterDate="2014-03-28" /><ClinVarAccession Acc="SCV000145948" OrgType="primary" OrganizationCategory="locus-specific database (LSDB)" Version="2" Type="SCV" OrgID="504197" DateUpdated="2016-10-05" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2002-05-29"><ReviewStatus>no assertion criteria provided</ReviewStatus><Description>Benign</Description></ClinicalSignificance><Assertion Type="variation to disease" /><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="5" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><GeographicOrigin>Austria</GeographicOrigin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="193" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><GeographicOrigin>Belgium</GeographicOrigin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><GeographicOrigin>Spain</GeographicOrigin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Ethnicity>Caucasian</Ethnicity><GeographicOrigin>American</GeographicOrigin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Ethnicity>Caucasian</Ethnicity><GeographicOrigin>Germany</GeographicOrigin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="4" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Ethnicity>Caucasian Southern African</Ethnicity><GeographicOrigin>South Africa</GeographicOrigin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="6" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Ethnicity>European, Asian, Oceanan</Ethnicity><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Ethnicity>Sinhalese</Ethnicity><GeographicOrigin>Sri Lanka</GeographicOrigin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1" /></ObservedData></ObservedIn><ObservedIn><Sample><Origin>unknown</Origin><GeographicOrigin>Brazil</GeographicOrigin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1" /></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><Name><ElementValue Type="Alternate">203G/A</ElementValue></Name><Name><ElementValue Type="Alternate">203G&gt;A</ElementValue></Name><AttributeSet><Attribute Type="Location">U43746.1:exon 2</Attribute></AttributeSet><AttributeSet><Attribute Type="HGVS">U43746.1:n.203G&gt;A</Attribute></AttributeSet></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">Breast-ovarian cancer, familial 2</ElementValue></Name><XRef DB="MedGen" ID="C2675520" Type="CUI" /></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="336350"><ClinVarSubmissionID localKey="SCRP_var_2130" submitter="Sharing Clinical Reports Project (SCRP)" submitterDate="2014-03-06" title="NM_000059.3:c.-26G&gt;A AND Breast-ovarian cancer, familial 2" /><ClinVarAccession Acc="SCV000189291" OrgType="primary" OrganizationCategory="consortium" Version="1" Type="SCV" OrgID="500037" DateUpdated="2016-10-05" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2011-03-17"><ReviewStatus>no assertion criteria provided</ReviewStatus><Description>Benign</Description></ClinicalSignificance><Assertion Type="variation to disease" /><ObservedIn><Sample><Origin>germline</Origin><Species>human</Species><AffectedStatus>not provided</AffectedStatus><NumberTested>86</NumberTested></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles">86</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="nucleotide change">5'UTR203G&gt;A</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">BRCA2</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">Breast-ovarian cancer, familial 2</ElementValue></Name></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="502757"><ClinVarSubmissionID localKey="NM_000059.3:c.-26G&gt;A|OMIM:612555" submittedAssembly="GRCh37" submitter="Michigan Medical Genetics Laboratories,University of Michigan" submitterDate="2016-04-21" /><ClinVarAccession Acc="SCV000195942" Version="1" Type="SCV" OrgID="308659" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2018-06-25" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2014-11-03"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Benign</Description></ClinicalSignificance><Assertion Type="variation to disease" /><AttributeSet><Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute><Citation><ID Source="PubMed">25741868</ID></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Tissue>Blood</Tissue><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_000059.3:c.-26G&gt;A</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">BRCA2</ElementValue></Symbol></MeasureRelationship><XRef DB="dbSNP" ID="1799943" Type="rsNumber" /></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="OMIM" ID="612555" Type="MIM" /></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="456411" SubmissionName="ENIGMA_2015-08-17"><ClinVarSubmissionID localKey="NM_000059.3:c.-26G&gt;A|OMIM:612555" submitter="Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)" submitterDate="2015-08-17" /><ClinVarAccession Acc="SCV000244917" OrgType="primary" OrganizationCategory="consortium" Version="1" Type="SCV" OrgID="504863" DateUpdated="2016-10-05" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2015-01-12"><ReviewStatus>reviewed by expert panel</ReviewStatus><Description>Benign</Description><Comment>Class 1 not pathogenic based on frequency &gt;1% in an outbred sampleset. Frequency 0.3689 (Asian), 0.04878 (African), 0.2282 (European), derived from 1000 genomes (2012-04-30).</Comment></ClinicalSignificance><Assertion Type="variation to disease" /><AttributeSet><Attribute Type="AssertionMethod">ENIGMA BRCA1/2 Classification Criteria (2015)</Attribute><Citation Type="general"><URL>https://submit.ncbi.nlm.nih.gov/ft/byid/hxnfuuxx/enigma_rules_2015-03-26.pdf</URL><CitationText>ENIGMA BRCA1/2 Classification Criteria (2015)</CitationText></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>curation</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><Name><ElementValue Type="Alternate">203 G&gt;A</ElementValue></Name><AttributeSet><Attribute Type="HGVS">NM_000059.3:c.-26G&gt;A</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">BRCA2</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">Breast-ovarian cancer, familial 2</ElementValue></Name><XRef DB="OMIM" ID="612555" Type="MIM" /></Trait></TraitSet><StudyDescription>ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) is a consortium focused on determining the clinical significance of variants in BRCA1, BRCA2 and other known/suspected breast cancer genes. http://enigmaconsortium.org/</StudyDescription></ClinVarAssertion><ClinVarAssertion ID="1120397" SubmissionName="SUB2591501"><ClinVarSubmissionID localKey="NM_000059.3:c.-26G&gt;A|OMIM:612555" submittedAssembly="GRCh37" submitter="Fulgent Genetics,Fulgent Genetics" submitterDate="2017-04-18" /><ClinVarAccession Acc="SCV000575763" Version="1" Type="SCV" OrgID="500105" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2018-02-22" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2016-02-08"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Benign</Description></ClinicalSignificance><Assertion Type="variation to disease" /><AttributeSet><Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute><Citation><ID Source="PubMed">25741868</ID></Citation></AttributeSet><ObservedIn><Sample><Origin>unknown</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_000059.3:c.-26G&gt;A</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">BRCA2</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="OMIM" ID="612555" Type="MIM" /></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="1449686" SubmissionName="SUB3915625"><ClinVarSubmissionID localKey="NM_000059.3:c.-26G&gt;A|OMIM:612555" submittedAssembly="GRCh37" submitter="Genome Diagnostics Laboratory,University Medical Center Utrecht" submitterDate="2018-04-17" /><ClinVarAccession Acc="SCV000743232" Version="1" Type="SCV" OrgID="274978" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2018-06-30" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2014-10-09"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Benign</Description></ClinicalSignificance><Assertion Type="variation to disease" /><AttributeSet><Attribute Type="AssertionMethod">ACGS Guidelines, 2013</Attribute><Citation><URL>https://submit.ncbi.nlm.nih.gov/ft/byid/yggjhwfz/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf</URL></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_000059.3:c.-26G&gt;A</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">BRCA2</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="OMIM" ID="612555" Type="MIM" /></Trait></TraitSet><StudyName>VKGL Data-share Consensus</StudyName></ClinVarAssertion><ClinVarAssertion ID="1450829" SubmissionName="SUB3885264"><ClinVarSubmissionID localKey="NM_000059.3:c.-26G&gt;A|OMIM:612555" submittedAssembly="GRCh37" submitter="DNA and Cytogenetics Diagnostics Unit,Erasmus Medical Center" submitterDate="2018-04-09" /><ClinVarAccession Acc="SCV000744375" Version="1" Type="SCV" OrgID="506497" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2018-04-19" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2015-09-21"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Benign</Description></ClinicalSignificance><Assertion Type="variation to disease" /><AttributeSet><Attribute Type="AssertionMethod">ACGS Guidelines, 2013</Attribute><Citation><URL>https://submit.ncbi.nlm.nih.gov/ft/byid/3yyso7ro/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf</URL></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>yes</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_000059.3:c.-26G&gt;A</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">BRCA2</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="OMIM" ID="612555" Type="MIM" /></Trait></TraitSet><StudyName>VKGL Data-share Consensus</StudyName></ClinVarAssertion></ClinVarSet>

</ReleaseSet>